Skip to Content

Sinopharm Group Co Ltd SHTDF

Morningstar Rating
$2.61 −0.05 (1.88%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SHTDF is trading at a 37% discount.
Price
$2.51
Fair Value
$5.40
Uncertainty
Extreme
1-Star Price
$8.36
5-Star Price
$2.37
Economic Moat
Wfsm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHTDF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.66
Day Range
$2.612.61
52-Week Range
$2.303.63
Bid/Ask
$2.43 / $2.72
Market Cap
$8.14 Bil
Volume/Avg
327 / 3,101

Key Statistics

Price/Earnings (Normalized)
6.38
Price/Sales
0.10
Dividend Yield (Trailing)
4.42%
Dividend Yield (Forward)
4.61%
Total Yield
4.42%

Company Profile

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Large Value
Total Number of Employees
113,362

Competitors

Valuation

Metric
SHTDF
MCK
CAH
Price/Earnings (Normalized)
6.3818.8816.36
Price/Book Value
0.77
Price/Sales
0.100.240.13
Price/Cash Flow
15.4611.66
Price/Earnings
SHTDF
MCK
CAH

Financial Strength

Metric
SHTDF
MCK
CAH
Quick Ratio
1.050.480.43
Current Ratio
1.320.920.98
Interest Coverage
14.7218.37
Quick Ratio
SHTDF
MCK
CAH

Profitability

Metric
SHTDF
MCK
CAH
Return on Assets (Normalized)
6.00%3.89%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
66.76%89.85%
Return on Assets
SHTDF
MCK
CAH
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpWtyslkftZhvmwj$70.5 Bil
COR
Cencora IncZtwhstwRfvqcy$48.4 Bil
CAH
Cardinal Health IncHfkzjnrdGwvsg$27.2 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoCqbrhw$8.2 Bil
SHTDY
Sinopharm Group Co Ltd ADRYywmq$8.0 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HWrldl$7.9 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HNkbkv$6.6 Bil
MAHLY
Medipal Holdings Corp ADRNzmh$3.2 Bil
MEPDF
Medipal Holdings CorpWszl$3.2 Bil

Sponsor Center